Ventricular assist device support in paediatric patients with restrictive cardiomyopathy—clinical outcomes and haemodynamics
European Journal of Cardio-Thoracic Surgery · 02.08.2024 · 66 (2)
DOI: 10.1093/ejcts/ezae277 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift European Journal of Cardio-Thoracic Surgery, online erschienen am 19.07.2024. Verfasst von Sofie Rohde und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardio-Thoracic Surgery, Erasmus University Medical Center, Rotterdam, Netherlands. Hauptthemen laut MEDLINE: Heart-Assist Devices, Cardiomyopathy, Restrictive, Hemodynamics. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: European Association for Cardio-Thoracic Surgery.
Abstract (Originalsprache)
OBJECTIVES Restrictive cardiomyopathy is rare and is generally associated with worse clinical outcomes compared to other cardiomyopathies. Ventricular assist device (VAD) support for these children is seldom applied and often hampered by the surgical difficulties. METHODS All paediatric (<19 years) patients with a restricted cardiomyopathy supported by a VAD from the EUROMACS database were included and compared to patients with a dilated cardiomyopathy (retrospective database analyses). Participating centres were retrospectively contacted to provide additional detailed echo and Swan Ganz measurements to analyse the effect of VAD support on pulmonary artery pressure and right ventricular function. RESULTS Forty-four paediatric VAD-supported patients diagnosed with restricted cardiomyopathy were included, with a median age at implantation of 5.0 years. Twenty-six of the 44 patient with a restricted cardiomyopathy survived to transplantation (59.1%), 16 died (36.4%) and 2 are still on ongoing VAD support (4.5%) after a median duration of support of 95.5 days (interquartile range 33.3–217.8). Transplantation probability after 1 and 2 years of VAD support in patients with a restricted cardiomyopathy were comparable to patients with a dilated cardiomyopathy (52.3% vs 51.4% and 59.5% vs 60.1%, P = 0.868). However, mortality probability was higher in the restricted cardiomyopathy cohort (35.8% vs 17.0% and 35.8% vs 19.0%, P = 0.005). Adverse event rates were high (cerebrovascular accident in 31.8%, pump thrombosis in 29.5%, major bleeding 25.0%, eventual biventricular support in 59.1%). In the atrially cannulated group, cerebrovascular accident and pump thrombosis occurred in twice as much patients (21.1% vs 40.0%, P = 0.595 and 15.8% vs 40.0%, P = 0.464; probably non-significant due to the small numbers). Pulmonary arterial pressures improved after implantation of a VAD, and 6 patients who were initially labelled as ineligible due to pulmonary hypertension could eventually be transplanted. CONCLUSIONS VAD support in children with a restricted cardiomyopathy is rarely performed. Mortality and adverse event rates are high. On the other hand, survival to cardiac transplantation was 59.1% with all patients surviving the 1st 30 days after cardiac transplantation. Pulmonary arterial pressures improved while on support, potentially making cardiac transplantation a viable option for previously ineligible children.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardio-Thoracic Surgery, Erasmus University Medical Center, Rotterdam, Netherlands.
- Department of Congenital Heart Disease and Pediatric Cardiology, Deutsches Herzzentrum der Charité, Berlin, Germany.
- Department of Surgery for Congenital. Heart Defects, Clinic for Pediatric Cardiac Surgery and Congenital Heart Defects, Heart and Diabetes Centre North Rhine-Westphalia, Ruhr-University of Bochum, Bad Oeynhausen, German…
- Department of Pediatric Cardiology and Cardiac Surgery, Bambino Gesù Hospital and Research Institute, Rome, Italy.
- Pediatric Cardiology Department, Hospital Universitario La Paz, Madrid, Spain.
- Department of Cardiac Surgery, Medical University of Vienna, Vienna, Austria.
ORCID-Profile: Eugen Sandica, Emanuela Angeli, Bart Meyns
Förderung
- European Association for Cardio-Thoracic Surgery
Zitieren
APA
Rohde, S., Miera, O., Sandica, E., Adorisio, R., Salas-Mera, D., Wiedemann, D., Sliwka, J., Amodeo, A., Gollmann-Tepeköylü, C., Napoleone, C. P., Angeli, E., Veen, K., de By, T., & Meyns, B. (2024). Ventricular assist device support in paediatric patients with restrictive cardiomyopathy—clinical outcomes and haemodynamics. European Journal of Cardio-Thoracic Surgery, 66(2). https://doi.org/10.1093/ejcts/ezae277
Vancouver
Rohde S, Miera O, Sandica E, Adorisio R, Salas-Mera D, Wiedemann D, et al. Ventricular assist device support in paediatric patients with restrictive cardiomyopathy—clinical outcomes and haemodynamics. European Journal of Cardio-Thoracic Surgery. 2024;66(2). doi:10.1093/ejcts/ezae277
BibTeX
@article{Rohde2024,
author = {Rohde, Sofie and Miera, Oliver and Sandica, Eugen and Adorisio, Rachele and Salas-Mera, Diana and Wiedemann, Dominik and Sliwka, Joanna and Amodeo, Antonio and Gollmann-Tepeköylü, Can and Napoleone, Carlo Pace and Angeli, Emanuela and Veen, Kevin and de By, Theo and Meyns, Bart},
title = {Ventricular assist device support in paediatric patients with restrictive cardiomyopathy—clinical outcomes and haemodynamics},
journal = {European Journal of Cardio-Thoracic Surgery},
year = {2024},
volume = {66},
number = {2},
doi = {10.1093/ejcts/ezae277}
}
EUVIMED